DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
Approval overview DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE is listed in Drugs@FDA under application 213300 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE Form and strength CAPSULE;ORAL - 0.5MG;0.4MG Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2024-07-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE is listed in Drugs@FDA under application 213300 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE Form and strength CAPSULE;ORAL - 0.5MG;0.4MG Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2024-07-18 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.